However, the integrity of GzmB function in CD4+ T cells may need to be maintained in order to optimize the GVT effect for certain types of blood cancers that are sensitive to GzmB-mediated killing by CD4+ T cells. Here, GZMB is linked to hematopoietic and lymphoid system neoplasm.